News Roundup: July 17 to July 23
Drug Topics
JULY 24, 2023
Your weekly roundup of the latest news from Drug Topics®.
Drug Topics
JULY 24, 2023
Your weekly roundup of the latest news from Drug Topics®.
PharmaVoice
JULY 24, 2023
Amid a wave of neuro R&D, scientists are taking an Alzheimer’s-like approach to developing the first disease-modifying treatments for Parkinson’s.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 24, 2023
Filling a prescription for a controlled substance requires more oversight than the average prescription.
PharmaVoice
JULY 24, 2023
Commercial teams need to accept the reality of declining pharmacy reimbursement as an important variable in their go-to-market equation.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
JULY 24, 2023
Exercise alone or vitamin D supplementation did not clinically improve cognition in adults with mild cognitive impairment.
Fierce Healthcare
JULY 24, 2023
As hospitals acquire ambulatory care centers, consumers are more likely to be forced to pay outpatient facility fees for routine care traditionally covered by physician offices at lower costs. | Customers are being surprised with larger medical bills to cover a hospital's operational expenses, and hospital consolidation is major driving factor, a Georgetown University report uncovered.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
ISPE
JULY 24, 2023
Implementing Cloud-Based Plant Management Software: Data Security Considerations for Pharma Companies Trudy Patterson Mon, 07/24/2023 - 11:13 iSpeak Blog iSpeak Implementing Cloud-Based Plant Management Software: Data Security Considerations for Pharma Companies Andreas Eschbach 24 July 2023 Cloud-based systems for plant process management (PPM) deliver significant benefits in terms of access, convenience and easy management.
Pharmacy Times
JULY 24, 2023
The once-daily therapeutic agent is effective for pediatric patients and pregnant women with HIV.
Fierce Healthcare
JULY 24, 2023
While payers are facing headwinds going into the latter part of this year, the ongoing financial impacts of healthcare's labor shortage will be felt in the hospital sector far longer, according to | While payers are facing headwinds going into the latter part of this year, the ongoing financial impacts of healthcare's labor shortage will be felt in the hospital sector far longer, according to a new report from analysts at Moody's Investors Service.
Pharmacy Times
JULY 24, 2023
Pharmacists must carefully consider safety concerns and patient privacy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
European Pharmaceutical Review
JULY 24, 2023
Roche and Alnylam Pharmaceuticals have agreed to jointly develop and commercialise zilebesiran, an RNAi therapeutic as a treatment for hypertension. Under the partnership, Alnylam will receive an upfront payment of $310 million from Roche and is eligible to receive development, regulatory and commercial milestones. Zilebesiran is an investigational, subcutaneously administered RNAi therapeutic targeting angiotensinogen (AGT).
Hospital Pharmacy Europe
JULY 24, 2023
A single subcutaneous injection of zilebesiran, which inhibits hepatic angiotensinogen synthesis, maintained a reduced 24-hour ambulatory blood pressure for 24 weeks, an international research team has found. If approved, the drug paves the way for a more convenient means of managing hypertension, which is normally treated with oral antihypertensive agents.
STAT
JULY 24, 2023
A new lawsuit accuses Cigna of using an algorithm to automatically deny claims in bulk instead of individually reviewing each case, putting patients on the hook for bills the health insurer otherwise would have paid. The complaint filed Monday in the Northern District of California says Cigna uses a system called PXDX to identify discrepancies between diagnoses and the tests and services it covers for those ailments.
The Checkup by Singlecare
JULY 24, 2023
It’s 2 a.m. and you’re lying in bed, wide awake. Despite tucking in hours ago, you have yet to fall asleep. Or, perhaps you drifted off for a few hours, but now peaceful slumber eludes you. Trouble falling asleep—or staying asleep—is a fairly common problem. Insomnia affects 10% to 30% of the adult population, according to studies , mostly impacting women, older adults, and people with medical or mental health issues.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
JULY 24, 2023
You don’t have to be an economist to understand the law of demand: The higher the price, the less likely a customer is to buy a product. This, of course, limits how much companies can charge. The law of demand applies to pharmaceuticals, but with one big difference. It’s not always the customer who decides that the price is too high. Often, it’s the insurer.
Pharmaceutical Technology
JULY 24, 2023
Verrica has received approval from the US FDA for its YCANTH to treat molluscum in adult and paediatric patients aged two years and above.
Drug Store News
JULY 24, 2023
Registration is now open for the Dec. 13 event in New York City.
Fierce Healthcare
JULY 24, 2023
A body of published academic data suggest that private equity ownership of healthcare providers frequently comes with higher costs and reduced quality, according to a systematic literature review p | Evidence of private equity ownership's detrimental impact on healthcare providers is "robust enough" to warrant greater scrutiny and possibly new regulations, researchers wrote in a recent 55-study literature review.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
JULY 24, 2023
The new launches span across single-serve meals, multi-serve meals, snacks and appetizers from many of its brands.
STAT
JULY 24, 2023
WASHINGTON — A key House committee announced its own plans to increase health care transparency and reduce some health care costs for patients on Monday, according to bill text obtained by STAT. The House Ways & Means Committee package includes a new provision that would ensure that patients in the Medicare program pay for medicines they pick up at the pharmacy counter based on the discounted price that insurers negotiate with drugmakers, instead of higher sticker prices, starting in
Fierce Healthcare
JULY 24, 2023
The Joint Commission unveiled the second tranche of its planned accreditation standards reduction, which will become effective Aug. 27. | The second tranche of an ongoing standards review primarily focused on accreditation requirements for non-hospital programs.
STAT
JULY 24, 2023
Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease. If things go well, Roche could pay Alnylam up to $2.8 billion in total. Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug
Pharmaceutical Commerce
JULY 24, 2023
Solution includes assistance with submitting regulatory submissions.
Drug Store News
JULY 24, 2023
Reed will be responsible for leading Walgreens Health Corners.
PharmExec
JULY 24, 2023
Collaboration aims to help pharmaceuticals drive efficiencies and business value.
STAT
JULY 24, 2023
MIAMI — Dr. Alfonso Sabater pulled up two photos of Antonio Vento Carvajal’s eyes. One showed cloudy scars covering both eyeballs. The other, taken after months of gene therapy given through eyedrops, revealed no scarring on either eye. Antonio, who’s been legally blind for much of his 14 years, can see again. The teen was born with dystrophic epidermolysis bullosa, a rare genetic condition that causes blisters all over his body and in his eyes.
pharmaphorum
JULY 24, 2023
Designing for behaviour change: The key to success in digital health Mike.
STAT
JULY 24, 2023
Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease. If things go well, Roche could pay Alnylam up to $2.8 billion in total. Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug
Drug Store News
JULY 24, 2023
The nail polish brand is prepping nails for the upcoming fall season with a new collection.
STAT
JULY 24, 2023
This essay is adapted from “ Random Acts of Medicine: The Hidden Forces That Sway Doctors, Impact Patients, and Shape Our Health ,” out now from Doubleday. “H oney, I forgot to duck,” Ronald Reagan said to his wife as he was wheeled to the operating room of George Washington University Hospital on March 30, 1981. He had just been shot and was bleeding into his left chest.
Fierce Healthcare
JULY 24, 2023
Virtual healthcare holds the key to not only increasing patient satisf | Virtual healthcare can not only improve outcomes and the patient experience, but it can also help reduce healthcare’s carbon footprint, according to Blue Shield of California.
STAT
JULY 24, 2023
Boston Children’s Hospital is located in the heart of the city’s bustling Longwood medical area. But within this dense urban landscape, there are pockets of solace for patients, their families and hospital employees. The hospital has 10 dedicated garden spaces on site. Dotted with statuary of snails, foxes, and frogs, these facilities are specially designed to accommodate the complicated needs of their patients.
Drug Store News
JULY 24, 2023
Amazon is adding new benefits to its FamilyFlex program that provides flexible scheduling and resources for employees and their family members.
Let's personalize your content